A New Paradigm for Drug Deuteration Based on Computed Binding Isotope Effects

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Computational Chemistry

Background:

• Deuterated drugs offer advantages like extended action and reduced market entry costs.
• Current deuteration strategies primarily aim to slow drug metabolism.
• An alternative paradigm is proposed to enhance drug efficacy and safety.

Purpose of the Study:

• To introduce a novel paradigm for drug deuteration utilizing binding isotope effects.
• To minimize deuterium release and reduce peak drug concentrations.
• To extend the duration of a drug's active form and mitigate side effects.

Main Methods:

• Investigating binding isotope effects as a key parameter in drug design.
• Employing theoretical calculations to identify suitable nonexchangeable hydrogen atoms.
• Analyzing deuterium's role in drug-target interactions.

Main Results:

• Binding isotope effects less than unity are crucial for minimizing deuterium release.
• This approach can lead to reduced peak concentrations and fewer side effects.
• Deuteration can be strategically used to prolong the therapeutic window.

Conclusions:

• A new paradigm for drug deuteration is proposed, focusing on binding isotope effects.
• This strategy offers potential for improved drug safety, efficacy, and cost-effectiveness.
• Theoretical calculations are essential for identifying optimal deuteration sites.